万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>生物科学>>生化与分子生物学
您的位置:万维书刊网 >>sci/e期刊大全 >>生物科学>>细胞生物学

FRONTIERS IN BIOSCIENCE-LANDMARK《生物科学前沿:里程碑》 (官网投稿)

简介
  • 期刊简称FRONT BIOSCI-LANDMRK
  • 参考译名《生物科学前沿:里程碑》
  • 核心类别 SCIE(2024版), 外文期刊,
  • IF影响因子
  • 自引率0.90%
  • 主要研究方向生物学-BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学;CELL BIOLOGY 细胞生物学

主要研究方向:

等待设置主要研究方向
生物学-BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学;CELL BIOLOGY 细胞生物学

FRONTIERS IN BIOSCIENCE-LANDMARK《生物科学前沿:里程碑》(不定期). Frontiers in Bioscience-Landmark (Landmark) is an international peer-reviewed open access journal o...[显示全部]
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊网址:https://www.fbscience.com/Landmark

3、投稿网址:

https://jour.ipublishment.com/bri/access/login

4、官网邮箱:如下。

5、期刊刊期:不定期出版。

2021416日星期五

                              

 

期刊邮箱【官网信息】

 

Editorial Office

Frontiers in Bioscience-Landmark Editorial Office

Front.Biosci.Landmark@fbscience.com

 

Editorial Board

For technical help about online submissions and website errors please contact:

tech@fbscience.com

For financial help about APC please contact us at:

finance@fbscience.com

 

投稿须知【官网信息】

 

Information for Authors

1. Manuscript Submission Overview

1.1. Types of Publications

Manuscripts submitted to Frontiers in Bioscience-Landmark (Landmark) should neither be under consideration for publication in another journal nor previously published in another journal. The main article types considered for publication are:

Articles: Reports of research on original works, includes Original Research, Short Communication, Rapid Report, Brief Report, etc. The journal considers all original research manuscripts provided that the work reports scientifically sound experiments and provides a substantial amount of new information. Authors should not unnecessarily divide their work into several related manuscripts, although Short Communications of preliminary, but significant, results will be considered. The quality and impact of the study will be considered during peer-review. Articles should follow but not limited to the following guidelines:

Randomised trials: CONSORT

Observational studies: STROBE

Qualitative research: SRQR

Diagnostic / prognostic studies: STARD

Animal pre-clinical studies: ARRIVE

Study protocols: SPIRIT

Clinical practice guidelines: AGREE

Reviews: This is a comprehensive overview of a specific hot topic aligned with addressing the aims and hypothesis through the literature. They are often written by leaders in a particular discipline. Reviews are often widely read (for example, by researchers looking for a full introduction to a field) and highly cited. Reviews commonly cite approximately 100 primary research articles. Systematic review is a type of literature review that uses systematic methods to collect secondary data, critically appraise research studies, and synthesize findings qualitatively or quantitatively. Systematic Reviews should follow the PRISMA guidelines.

Case Report: A case report is a detailed report of the symptoms, signs, diagnosis, treatment, and follow-up of an individual patient in medicine. Case reports may contain a patient's demographic profile but usually describe an unusual or novel occurrence. Some case reports also contain a literature review of other reported cases. Case reports are professional narratives that provide feedback on clinical practice guidelines and offer a framework for early signals of effectiveness, adverse events, and cost. They can be shared for medical, scientific, or educational purposes. Case Report should follow the CARE guidelines.

Editorial: Editorials are opinion articles from the editor or an invited author. When submitted by an invited contributor, editorials may introduce the subject being brought into focus in a special issue or thematic section. Editorials may comment on one or more articles in the same Landmark issue or on an area of current interest in Bioscience. They should be brief and focused. Editorials should not exceed 1,000 words, 15 references, and 1 table or figure. Editorials may have a maximum of 3 authors. The body of the Editorial can be continuous text or divided into subsections. There is no abstract. Editorials on topics of current interest are welcome.

See more information about these article types.

1.2. Accepted File Formats

Authors must use the Microsoft Word template available on our website to prepare their manuscript. If this requirement presents a problem, please contact the Editorial Office (Front.Biosci.Landmark@fbscience.com). Accepted file formats are:

Microsoft Word: Manuscripts must be converted into a single file before submission. When preparing manuscripts in Microsoft Word, the Landmark Microsoft Word template file must be used.

Language: Manuscripts should be written in clear, concise English and should contain all essential data in order to make the presentation clear and the results of the study replicable. If the author is not a native English speaker, we recommend that you have your manuscript professionally edited before submission or read by a colleague proficient in English.

Figures: Please save and submit figures as jpg. or tif. files (see below for further details).

Supplementary Materials: These materials may be in any format, but it is recommended that authors use common, non-proprietary formats where possible (see below for further details).

1.3. Submission Process

Manuscripts that are ready for submission should be scientifically sound and without errors in English (including spelling, grammar, proper sentence flow, etc.).

Properly-formatted manuscripts should be submitted using the online submission page. Figures should be named according to the following format: figure1.jpg, figure2.jpg, etc., and submitted as separate files. TIFF images should not contain layers and preferably use Lempel-Ziv-Welch (LZW) compression as it does not reduce image quality. JPEG (only if originally saved at the highest quality) images are also acceptable. Tables can be inserted into the end of main manuscript or submitted as separate files.

Please read the checklist carefully before submission.

Manuscripts for Landmark should be submitted online at https://jour.ipublishment.com/bri. The submitting author, who is generally the corresponding author, is responsible for the manuscript during the submission and peer-review process. The submitting author must ensure that all eligible co-authors have been included in the author list (read the criteria to qualify for authorship) and that they have all read and approved the submitted version of the manuscript. To submit your manuscript, register and log in to the submission website.

ORCID is an optional field which the submitting author can fill in. Landmark uses ORCID to clearly link authors and reviewers—and all their name variants—with their research work, by embedding ORCID IDs into their publication metadata and displaying them on finished publications. Therefore, we recommend that the author complete this optional field.

When a manuscript is submitted, the corresponding author will receive a response within a few days regarding the suitability of the manuscript for publication in the Landmark.

All manuscripts will be peer-reviewed by experts. A manuscript will be published if the manuscript receives a high impact score. Every attempt will be made to keep the duration of the review period to a minimum.

2. Manuscript Preparation

2.1. General Guidelines

Read submission review Guidelines to Authors, view a properly formatted sample document ready for submission.

2.1.1. Title Page (word template)

There should be a title page with the following:

Title

The title of the manuscript in sentence form. No abbreviations other than gene names or abbreviations in common use are allowed.

Full Names, Email Address and Affiliations Including Postal Codes of All Authors

Authors affiliations should reflect where their primary contribution to the research was made. Affiliations of the authors indicated by numbers (not symbols); equal contribution indicated by †.

Corresponding Author and Corresponding Email Address

Clearly indicate who will handle correspondence at all stages of review, publication, and post-publication. Responsibilities includes answering any future queries concerning Methodology and Materials. Landmark allows up to two corresponding authors and when two are listed, no priority is given to either. The submitting author is required to be a corresponding author. Please provide the corresponding author Name, full postal address, including street number and name, and institutional email address.

Author Contributions

Use this section to acknowledge contributions from each author listed on the manuscript. Authorship must include, and be limited to, those who have contributed substantially to the work. Please read the section concerning the criteria to qualify for authorship carefully.

Ethics Approval and Consent to Participate

This section is required for all papers involving humans or animals.

Acknowledgment

Use this section to acknowledge contributions from non-authors.

Funding

List funding sources. As this section contains important information and many funding bodies require inclusion of grant numbers here, please check carefully that manuscript details are accurate and use standard spelling of funding agency names at https://search.crossref.org/funding, as errors may affect your future funding.

Conflict of Interest

This section is required for all papers. Please read the section concerning the conflict of Interest carefully.

2.1.2. Cover Letter (word template)

Summarize briefly the important points of the submitted work including a brief description of the study to be submitted, that it is an original study presenting novel work, that it has not been previously submitted to or accepted by any other journal, that is has been approved by all authors, that ethics approval and written informed consent have been obtained, and explain whether any author has a conflict of interest.

2.1.3. Manuscript Content

The research articles, and technical notes contain a title, table of contents, abstract, keywords, introduction, materials and methods, result, discussion, author contributions, acknowledgment, conflict of interest, references, legends to figures, tables and figures, running title. If necessary, the result and discussion sections may be combined. Review articles and Case Report contain a title, table of contents, abstract, keywords, introduction, body of text, author contributions, acknowledgment, conflict of interest, references, legends to figures, tables and figures, running title. Editorial contain a title, body of text, conflict of interest, references.

2.2. Format of Manuscript

2.2.1. General Formatting Guidelines

Format, revise, and correct the manuscript and save it as a MS Word document (not as a text or any other type of file). It is important that manuscripts should be written in clear, concise English and should be submitted free of grammar, spelling or scientific errors. Subsequent to submission of the manuscript, please do not send any other revised form of the same document. Such documents will not be used.

If you are including text, tables or figures that were previously published, please obtain the permission of the publisher. By simply calling or writing to the publisher, you can easily obtain such permissions.

If you are referring to previously published text, figure or table, please add the following comment to text, the figure or table legend "Reproduced with permission from, (ref #)".

All terms such as et al, in situ, in vitro, in vivo, etc. should be italicized.

Please do not use automatic numbering in table of contents, titles, subtitles or references. The numbering used by Word is proprietary and does not allow conversion to HTML documents. Please remove automatic numbering and manually number numbered items in text.

All supplementary materials (where applicable) should be submitted through online submission system as separated files. All supplementary figures and tables must be referred to by sequential numbers in text.

Do not include footnotes throughout the text. All footnotes must be included at the end of the references and referred to sequentially by superscripted numbers both in text and in footnotes.

All files must be scanned for viruses prior to submission.

Page Layout: General.

Times New Roman. Font size 12. Single line spacing. Alignment Justified.

The first line indents 0.5 inch of a new paragraph.

Sub-headings and general headings should be presented in lower case letters (not capitals).

Use either British English or American English spelling throughout your manuscript, but not both.

Do not use page breaks in your manuscript.

Divide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 (then 1.1.1, 1.1.2, ...), 1.2, etc. Use this numbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be given a brief heading.

2.2.2. Manuscripts

Title

The title of the manuscript in sentence form. No abbreviations other than gene names or abbreviations in common use are allowed.

Table of Contents

Number section and subsection throughout the text according to the numbers in the table of contents.

Abstract

This section should be continuous (not structured) and without references. Abbreviations that appear once only should be defined in full unless they correspond to a gene name. If abbreviations appear more than once, the definition should be provided once, and then subsequently used throughout the abstract.

Keywords

Include at least five key words. Include the word "Review" for reviews. The first letter and abbreviations must be capped.

Introduction

State the objectives of the work and provide an adequate background to clarify why the study was undertaken and what hypotheses were tested, avoiding a detailed literature survey or a summary of the results. The information in this section should always be referenced and must discuss the literature.

Materials and Methods

The materials used and procedures conducted should be described with sufficient detail to allow others to replicate and build on published results. New methods and protocols should be described in detail while well-established methods can be briefly described and appropriately cited. Methods that have been published in detail elsewhere should not be described in detail and avoid unnecessary detailed descriptions of widely used techniques. SI Units should be used throughout the text. Reports of experiments involving patients and healthy volunteers must describe the steps taken to obtain consent and to maintain confidentiality. Experiments involving animals must conform to accepted ethical standards.

Statistical analyses should provide the name of the statistical test used, the number for each analysis, the comparisons of interest, the alpha level and the actual p-value for each test. It should be clear which statistical test was used to generate every p-value. Error bars on graphs should be clearly labeled, and it should be stated whether the number following the ± sign is a standard deviation or a standard error. The word ‘significant’ should only be used when referring to statistically significant results and should be accompanied by the relevant p-value. Significance indicators should be used on graphs and tables, and should be described in the figure or table legend, clearly indicating which groups are being compared. Describe any statistical software used to perform analyses.

Results

Include a concise summary of the data presented in all display items (figures and tables). Excessive elaboration of data shown in display items should be avoided. Numerical data should be analyzed using appropriate statistical tests described in the Experimental Design and Statistical Analysis section. Authors must provide detailed information for each statistical test applied. If some references are needed to support the results they can be inserted in the Discussion section.

Reproducibility of Results and Statistical Analysis:

Submission of data for publication is an indication that the authors are confident of data reproducibility. Appropriate statistical analysis should be used to determine that the findings are significant. The term "significant" should be used only if such determination has been made. The probability of the significance should be stated. When reporting a new assay, the following data should be listed:

Within-assay variability

Between-assay variability

Slope of the dose-response curve

Mid-range of assay

Sensitivity. Least detectable concentration

Specificity

Parallelism of the standard and the unknown on recovery

Comparison with another method for the detection of the compound

Discussion

This section should explore the significance of the results of the work, not repeat them. A combined Results and Discussion section is often appropriate. Avoid extensive citations and an overly discussion of published literature.

Informed Consent Statement

Any research article describing a study involving humans should contain this statement. Patients have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, date of birth or hospital numbers, images or statements should not be included in the manuscript unless the information is essential for scientific purposes and the patient (or parent or guardian) has provided written informed consent for publication. A statement must be included in the manuscript declaring that the patient, parent, guardian, or next of kin (in case of deceased patients) provided written informed consent for the publication of any associated data and accompanying images. The consent form must be made available to the Editor if requested, and will be treated confidentially.

References

Abbreviations

Figure Legends (do not place the reference to figure legends in table of contents)

Tables (do not place the references to tables in table of contents)

Running Title (do not place the reference to the running title in table of contents)

Notes:

Place a hard return after each paragraph.

Indent each paragraph 0.5 inch.

Place two returns after section titles and one return after subsection titles.

Please cite references throughout the text in sequential numbers and place references inside parenthesis at the end of sentences throughout the text.

2.2.3. Page Arrangement

Article (word template)

Review and Case Report (word template)

Editorial (word template)

2.2.4. References

Reference list is sorted numerically. The reference list should be limited to only those citations essential to the presentation.

Please verify the accuracy of all references and check that all references have been cited in the text.

Please list all authors’ names if the authors number less than 6. For the authors of more than 6, use "et al.".

Please List the full name of journal, do not abbreviate the page number.

Use the [number] for the references in the text.

Sample reference citation (Download EndNote style).

1) Journal:

Single Author

[1] Boyden EA. A critique of the international nomenclature on bronchopulmonary segments. Dis Chest. 1953; 23: 266-269.

Two Authors

[2] McNarry AF, Goldhill DR. Simple bedside assessment of level of consciousness: comparison of two simple assessment scales with the Glasgow Coma scale. Anaesthsia. 2004; 59: 34-37.

More than 6 authors

[3] Churpek MM, Yuen TC, Park SY, Churpek MM, Yuen TC, Park SY, et al. Derivation of a cardiac arrest prediction model using ward vital signs. Crit Care Med. 2012; 40: 2102-2108.

(2) Book:

[1] Kolacek S, Mestrovic J. Vascular access, including complications. In: Langnas AN, Goulet O, Quigley EMM,

Tappenden KA, editors. Intestinal failure, 1st ed. Malden, MA: Blackwell Publishing; 2008. p. 142-150.

[2] Lang TA, Secic M. How to report statistics in medicine. Philadelphia: American College of Physicians; 1997.

(3) Patent:

[1] Anninos PA, Tsagas N. Electronic apparatus for treating epileptic epileptic individuals. USA patent NO. 5453072, 1995.

(4) If there are non-English journals in the reference, please insert the journal language as the ending:

[1] Wiese L, Kurtzhals J A, Penkowa M. Neuronal apoptosis metallothionein expression. German Neurology 2006; 200: 216-226. (In German)

(5) Website:

[1] Ricou B, Bandschap O. Propofol and perioperative inflammation. ClinicalTrials.gov 2010. accessable on: https://clinicaltrials.gov/ct2/show/NCT01115179.

2.2.5. Abbreviations

Naming of chemicals should follow that outlined in Chemical Abstracts Service.

Use standard abbreviations where possible. Use the generic name of any drug unless making claims about a specific brand or formulation.

New abbreviations must be defined at first usage within the manuscript.

2.2.6. Tables

Include tables at the end of the document.

Do not submit tables in any other format such as an image, Excel file, PDF file, etc.

Each table must be a real table with columns, rows and cells.

Do not use tab to create tables.

Each piece of information should reside in its own cell.

Tables must be numbered sequentially in the text and in the table title.

Do not place any period after the table title.

Do not use any numbering style other than 1, 2, etc.

Each table should have a short title. Any other text should be included at the bottom of the table and not in the table title.

Please refer to any notation within the table with sequential superscripted numbers and not by any other attribute such as a, #, *, etc.

Please cite references in the right column by numbers referenced in the reference section. Do not use the name of author followed by et al.

If possible, please do not use abbreviations in tables.

If abbreviations are used, please list them below the table such as IFN: interferon.

……


  • 万维QQ投稿交流群    招募志愿者

    版权所有 Copyright@2009-2015豫ICP证合字09037080号

     纯自助论文投稿平台    E-mail:eshukan@163.com


投稿问答最小化  关闭